A new obesity drug being researched in Ireland has been found to have cut fat by 11 percent.
The drug Cagrilintide is taken once a week through an injection and increases people's sense of 'saiety', meaning it makes users feel less hungry.
It comes after trials involving 706 people took place over six-and-a-half-months in 2019.
Researchers say the results have 'exceeded expectations' and are looking towards conducting more trials.
Those receiving the highest dose of the drug in the trial lost 10.8% of their weight, which is around two stone for most people.
However obesity specialist at St Vincents University Hospital in Dublin Carel Le Roux says the drug would be quite expensive:
"What we can do is a health economic assessment meaning we can see which patients will benefit most. And the way we measure it is we look at can we make you live an extra year with a quality life.
So it's not only making you live longer it's making you live longer and better."
